ProKidney Q3 net loss available to Class A stockholders more than doubles year over year to $35.59 million
ProKidney Q3 net loss available to Class A stockholders more than doubles year over year to $35.59 m
ProKidney Q3 net loss available to Class A stockholders more than doubles year over year to $35.59 m